All Stories

  1. Surface functionalization by covalent immobilization of an innovative carvacrol derivative to avoid fungal biofilm formation

    Article • AMB Express, February 2015, Springer Science + Business Media

    Professor Sebastien Papot

  2. A mechanically interlocked molecular system programmed for the delivery of an anticancer drug

    Article • Chemical Science, January 2015, Royal Society of Chemistry

    Professor Sebastien Papot

  3. A dendritic β-galactosidase-responsive folate–monomethylauristatin E conjugate

    Article • Chemical Communications, January 2015, Royal Society of Chemistry

    Professor Sebastien Papot

  4. Evaluation of Cytotoxic Properties of a Cyclopamine Glucuronide Prodrug in Rat Glioblastoma Cells and Tumors

    Article • Journal of Molecular Neuroscience, October 2014, Springer Science + Business Media

    Professor Sebastien Papot

  5. ChemInform Abstract: β-Glucuronidase-Responsive Prodrugs for Selective Cancer Chemotherapy: An Update

    Article • ChemInform, April 2014, Wiley

    Professor Sebastien Papot

  6. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update

    Article • European Journal of Medicinal Chemistry, March 2014, Elsevier

    Professor Sebastien Papot

  7. Oxidative decarboxylation of diclofenac by manganese oxide bed filter

    Article • Water Research, September 2013, Elsevier

    Professor Sebastien Papot

  8. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy

    Article • European Journal of Medicinal Chemistry, September 2013, Elsevier

    Professor Sebastien Papot

  9. A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts

    Article • Leukemia Research, August 2013, Elsevier

    Professor Sebastien Papot

  10. An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process

    Article • Organic & Biomolecular Chemistry, January 2013, Royal Society of Chemistry

    Professor Sebastien Papot

  11. NDMA Formation by Chloramination of Ranitidine: Kinetics and Mechanism

    Article • Environmental Science & Technology, October 2012, American Chemical Society (ACS)

    Professor Sebastien Papot

  12. Inside Cover: The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy (Angew. Chem. Int. Ed. 46/2012)

    Article • Angewandte Chemie, October 2012, Wiley

    Professor Sebastien Papot

  13. Innentitelbild: The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy (Angew. Chem. 46/2012)

    Article • Angewandte Chemie, October 2012, Wiley

    Professor Sebastien Papot

  14. The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy

    Article • Angewandte Chemie, September 2012, Wiley

    Professor Sebastien Papot

  15. The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy

    Article • Angewandte Chemie, September 2012, Wiley

    Professor Sebastien Papot

  16. 199 Cytotoxic Activity of a Cyclopamine Glucuronide Prodrug Against Glioblastoma Cells

    Article • European Journal of Cancer, July 2012, Elsevier

    Professor Sebastien Papot

  17. Synthesis and Antitumor Efficacy of a β-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin

    Article • Journal of Medicinal Chemistry, May 2012, American Chemical Society (ACS)

    Professor Sebastien Papot

  18. Second generation specific-enzyme-activated rotaxane propeptides

    Article • Chemical Communications, January 2012, Royal Society of Chemistry

    Professor Sebastien Papot

  19. A self-immolative dendritic glucuronide prodrug of doxorubicin

    Article • MedChemComm, January 2012, Royal Society of Chemistry

    Professor Sebastien Papot

  20. Formal synthesis of TMC-69-6H via a one-pot enantioselective domino proline-mediated aldol/olefin homologation procedure

    Article • Tetrahedron, January 2012, Elsevier

    Professor Sebastien Papot

  21. Inside Cover: A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier (ChemMedChem 12/2011)

    Article • ChemMedChem, December 2011, Wiley

    Professor Sebastien Papot

  22. A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier

    Article • ChemMedChem, August 2011, Wiley

    Professor Sebastien Papot

  23. A Galactosidase-Responsive “Trojan Horse” for the Selective Targeting of Folate Receptor-Positive Tumor Cells

    Article • ChemMedChem, March 2011, Wiley

    Professor Sebastien Papot

  24. A new cyclopamine glucuronide prodrug with improved kinetics of drug release

    Article • Organic & Biomolecular Chemistry, January 2011, Royal Society of Chemistry

    Professor Sebastien Papot

  25. ChemInform Abstract: A New Spacer Group Derived from Arylmalonaldehydes for Glucuronylated Prodrugs.

    Article • ChemInform, June 2010, Wiley

    Professor Sebastien Papot

  26. Dietary docosahexaenoic acid proposed to sensitize breast tumors to locally delivered drug

    Article • Clinical Lipidology, April 2010, Future Medicine

    Professor Sebastien Papot

  27. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma

    Article • European Journal of Medicinal Chemistry, April 2010, Elsevier

    Professor Sebastien Papot

  28. ChemInform Abstract: Cyanuric Chloride: An Efficient Reagent for the Lossen Rearrangement.

    Article • ChemInform, February 2010, Wiley

    Professor Sebastien Papot

  29. Cyanuric chloride: an efficient reagent for the Lossen rearrangement

    Article • Tetrahedron Letters, December 2009, Elsevier

    Professor Sebastien Papot

  30. Rotaxane-Based Propeptides: Protection and Enzymatic Release of a Bioactive Pentapeptide

    Article • Angewandte Chemie, August 2009, Wiley

    Professor Sebastien Papot, Dr Frédéric Coutrot

  31. Rotaxane-Based Propeptides: Protection and Enzymatic Release of a Bioactive Pentapeptide

    Article • Angewandte Chemie, August 2009, Wiley

    Professor Sebastien Papot, Dr Frédéric Coutrot

  32. Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy

    Article • Bioorganic & Medicinal Chemistry, September 2008, Elsevier

    Professor Sebastien Papot

  33. Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy

    Article • Anti-Cancer Agents in Medicinal Chemistry, August 2008, Bentham Science Publishers

    Professor Sebastien Papot

  34. Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy

    Article • Anti-Cancer Agents in Medicinal Chemistry, August 2008, Bentham Science Publishers

    Professor Sebastien Papot

  35. Efficient Regio- and Stereoselective Synthesis of 1-β-O-Glucuronyl Carbamates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates.

    Article • ChemInform, December 2007, Wiley

    Professor Sebastien Papot

  36. First O-Glycosylation of Hydroxamic Acids.

    Article • ChemInform, September 2007, Wiley

    Professor Sebastien Papot

  37. Efficient Regio- and Stereoselective Synthesis of 1-β- O -Glucuronyl Carba­mates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates

    Article • Synlett, July 2007, Thieme Publishing Group

    Professor Sebastien Papot

  38. First O -Glycosylation of Hydroxamic Acids

    Article • The Journal of Organic Chemistry, May 2007, American Chemical Society (ACS)

    Professor Sebastien Papot

  39. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) β-glucuronide and β-galactoside for application in selective prodrug chemotherapy

    Article • Bioorganic & Medicinal Chemistry Letters, February 2007, Elsevier

    Professor Sebastien Papot

  40. A New Simple and Convenient Method for the Synthesis of Substituted 2,6,9-Trioxabicyclo[3.3.1]-nona-3,7-dienes from Arylmalondialdehydes.

    Article • ChemInform, November 2006, Wiley

    Professor Sebastien Papot

  41. A new simple and convenient method for the synthesis of substituted 2,6,9-trioxabicyclo[3.3.1]-nona-3,7-dienes from arylmalondialdehydes

    Article • Tetrahedron Letters, August 2006, Elsevier

    Professor Sebastien Papot

  42. Alchimies futures : compte rendu de l'expérience ESYOP

    Article • Comptes Rendus Chimie, January 2006, Cellule MathDoc/CEDRAM

    Dr Stéphane Gastaldi, Professor Sebastien Papot

  43. Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy

    Article • Letters in Drug Design & Discovery, December 2005, Bentham Science Publishers

    Professor Sebastien Papot

  44. Design of Selectively Activated Anticancer Prodrugs: Elimination and Cyclization Strategies

    Article • Current Medicinal Chemistry - Anti-Cancer Agents, March 2002, Bentham Science Publishers

    Professor Sebastien Papot

  45. Synthesis and β-Glucuronidase Mediated Cleavage of an Alcohol Prodrug Incorporating a Double Spacer Moiety

    Article • Synlett, January 2002, Thieme Publishing Group

    Professor Sebastien Papot

  46. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice

    Article • Brain Research, December 2001, Elsevier

    Professor Sebastien Papot

  47. ChemInform Abstract: Enantioselective Synthesis of Sulindac.

    Article • ChemInform, April 2001, Wiley

    Professor Sebastien Papot

  48. Synthesis of indomethacin analogues for evaluation as modulators of MRP activity

    Article • Bioorganic & Medicinal Chemistry, March 2001, Elsevier

    Professor Sebastien Papot

  49. Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard

    Article • Bioorganic & Medicinal Chemistry Letters, August 2000, Elsevier

    Professor Sebastien Papot

  50. Study of biscarbamates derived from 2-aminobenzylamines as models for alcohol prodrugs

    Article • Tetrahedron, April 1999, Elsevier

    Professor Sebastien Papot

  51. A new spacer group derived from arylmalonaldehydes for glucuronylated prodrugs

    Article • Bioorganic & Medicinal Chemistry Letters, September 1998, Elsevier

    Professor Sebastien Papot